Redeye remains confident on the case as we see solid prospects for continued rapid growth and good operating leverage. In the third quarter, Freemelt made further progress with three new machine orders and four printers installed at customer sites. Q3 sales and earnings were both somewhat better than expected and cash flow saw a major improvement driven by customer payments.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/